Glivec | search
Click here to view Glivec news from 60+ newspapers.
Bookmark or Share- Imatinib (Glivec) | Cancer information | Cancer Research UKImatinib (Glivec) is a targeted cancer drug. It as a treatment for a number of different types of cancer. Find out about how you have it, possible side effects and other important information.
- Gleevec: Uses, Dosage, Side Effects - Drugs.comGleevec is a targeted therapy cancer treatment used to treat specific types of leukemia (blood cancer), bone marrow disorders, skin cancers and certain tumors of the stomach and digestive system. Gleevec (imatinib) is an oral tablet that is taken once or twice a day.
- Imatinib - WikipediaImatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2] Imatinib is a small molecule inhibitor targeting multiple tyrosine kinases such as CSF1R, ABL, c-KIT, FLT3, and PDGFR-β.
- Glivec | European Medicines Agency (EMA)Glivec is used when the patients are ‘Philadelphia chromosome positive’ (Ph+). This means that some of their genes have re-arranged themselves to form a special chromosome called the Philadelphia chromosome. Glivec is used in adults and children who have been newly diagnosed with Ph+ CML and who are not eligible for a bone marrow transplant.
- Glivec (STI571, imatinib), a rationally developed, targeted ... - NatureA lead compound identified in a screen for inhibitors of protein kinase C was optimized to give a methyl-piperazine derivative that was originally named STI571 (imatinib, now known as Glivec or...
More
